Lv01
0 积分 2024-01-25 加入
Primary Glomerulonephritis in Mainland China: An Overview
4小时前
待确认
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198
5小时前
已完结
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024
2天前
已完结
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
19天前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
2个月前
已完结
High levels of AXL expression in untreated EGFR‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib
2个月前
已完结
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
2个月前
已完结
Long-term trends and future projections of CLL burden in China: a comprehensive analysis from 1990 to 2030 using GBD data
2个月前
已完结
Abstract A100: AXL Inhibitor AB801 Increases the Anti-Tumor Efficacy of KRAS Inhibition
2个月前
已完结
我国青少年右美沙芬滥用趋势、成因与管控对策
2个月前
已完结
皖公网安备34019202002308
